SPONSOR
Centro di Riferimento Oncologico - Aviano
Total Trials
2
Recruiting
2
Phases
N/A
Centro di Riferimento Oncologico - Aviano is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Pleural Mesothelioma Malignant, Glioma.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Centro di Riferimento Oncologico - Aviano
How many clinical trials has Centro di Riferimento Oncologico - Aviano sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Centro di Riferimento Oncologico - Aviano, of which 2 are actively recruiting participants. These trials cover conditions including Pleural Mesothelioma Malignant, Glioma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Centro di Riferimento Oncologico - Aviano research focus on?
Centro di Riferimento Oncologico - Aviano clinical trials span Pleural Mesothelioma Malignant, Glioma. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Centro di Riferimento Oncologico - Aviano clinical trial?
To participate in a Centro di Riferimento Oncologico - Aviano trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Centro di Riferimento Oncologico - Aviano trials with current recruitment status updated daily.
Clinical Trials by Centro di Riferimento Oncologico - Aviano
NCT06637345
Recruiting
Identification of Prognostic and Predictive Biomarkers of Toxicity in Patients With Malignant Pleural Mesothelioma and Treated With High Doses of Radiotherapy (MESORTIBO)
Pleural Mesothelioma Malignant
NCT06055517
Recruiting
Use of Pulsed Low-dose Rate Re-irradiation for Recurrent Glioma (PULSAR)
Glioma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology